John E Davis Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 2 weeks ago
John E Davis has an estimated net worth of at least $11.0 million*, as of Oct. 29, 2025. They own 193,842 shares of AORT stock. They have sold 84,938 shares of AORT stock since 2021, for an estimated $1.5 million.
John E Davis $AORT SEC Form 4 Insider Trading
John E Davis has filed a total of 20 insider trades in $AORT since 2021. Their most recent trade was a sale of 5,000 shares, made on Dec 15, 2025. Their largest trade was a sale of 15,100 shares, made on Mar 11, 2025. We estimate that they now own 193,842 shares of $AORT, worth an estimated $9.4 million.
Insider Trading at $AORT
There have been a total of 191 insider trades reported at $AORT since 2021, with 0 shares purchased and 1.2 million shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, Marshall S. Stanton, and James P Mackin. The most recent trade was a sale of 5,000 shares reported by John E Davis (Chief Commercial Officer), made on Dec 15, 2025.
History of Insider Stock Trades by John E Davis
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AORT
|
Sale | 5,000 | Dec 15, 2025 | Dec. 17, 2025, 4:47 p.m. |
|
AORT
|
Sale | 6,393 | Nov 14, 2025 | Nov. 18, 2025, 2:03 p.m. |
|
AORT
|
Sale | 6,394 | Nov 17, 2025 | Nov. 18, 2025, 2:03 p.m. |
|
AORT
|
Sale | 6,563 | Nov 13, 2025 | Nov. 14, 2025, 1:10 p.m. |
|
AORT
|
Sale | 3,373 | Nov 10, 2025 | Nov. 12, 2025, 9:07 p.m. |
|
AORT
|
Sale | 10,802 | Aug 12, 2025 | Aug. 14, 2025, 9:56 a.m. |
|
AORT
|
Sale | 15,100 | Mar 11, 2025 | March 12, 2025, 3:32 p.m. |
|
AORT
|
Sale | 2,618 | Mar 06, 2025 | March 10, 2025, 5:06 p.m. |
|
AORT
|
Sale | 2,846 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 591 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 985 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 2,035 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 2,022 | Mar 05, 2024 | March 7, 2024, 7:14 p.m. |
|
AORT
|
Sale | 584 | Feb 27, 2024 | Feb. 29, 2024, 6:32 p.m. |
|
AORT
|
Sale | 2,060 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
AORT
|
Sale | 496 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
AORT
|
Sale | 13,562 | Jan 02, 2024 | Jan. 4, 2024, 5:22 p.m. |
|
AORT
|
Sale | 1,121 | Mar 02, 2023 | March 3, 2023, 6:52 p.m. |
|
AORT
|
Sale | 1,208 | Feb 27, 2023 | March 1, 2023, 7:44 p.m. |
|
AORT
|
Sale | 1,185 | Feb 27, 2023 | March 1, 2023, 7:44 p.m. |
CRY
|
Purchase | 600 | Nov 29, 2021 | Dec. 1, 2021, 5:14 p.m. |
$AORT Executives and Stock Owners with Insider Trades
-
Jean F Holloway, SVP, General Counsel
-
Marshall S. Stanton, SVP, Clinical & MD Affair
-
James P Mackin, President & CEO
-
Amy Horton, VP, Chief Accounting Officer
-
John E Davis, Chief Commercial Officer
-
Matthew A Getz, VP, Human Resources
-
Andrew M Green, VP Regulatory
-
Dennis B Maier, SVP, Operations
-
Rochelle L. Maney, VP, Quality
-
David Ashley Lee, Executive VP, COO & CFO
-
John E Davis, Senior VP, Global Sales
-
Florian Tyrs, VP, Global Operations
-
Lance A Berry, Executive VP, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.